Clicky

Avalon GloboCare Corp.(ALBT)

Description: Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.


Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Vesicles Bioproduction

Home Page: www.avalon-globocare.com

ALBT Technical Analysis

4400 Route 9 South
Freehold, NJ 07728
United States
Phone: 732 780 4400


Officers

Name Title
Dr. David K. Jin M.D., Ph.D. CEO, Pres & Director
Ms. Luisa Ingargiola Chief Financial Officer
Ms. Meng Li COO, Sec. & Director

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 9.4262
Price-to-Sales TTM: 35.6002
IPO Date: 2016-12-06
Fiscal Year End: December
Full Time Employees: 5
Back to stocks